Bodycote (LON:BOY)‘s stock had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday.
Several other equities research analysts have also weighed in on BOY. Bank of America lowered their price objective on Bodycote from GBX 850 ($11.11) to GBX 780 ($10.19) and set an “underperform” rating on the stock in a research note on Tuesday. Goldman Sachs Group downgraded Bodycote to a “sell” rating and reduced their target price for the stock from GBX 820 ($10.71) to GBX 715 ($9.34) in a report on Tuesday. Peel Hunt reissued a “buy” rating on shares of Bodycote in a report on Tuesday, December 11th. Liberum Capital downgraded Bodycote to a “hold” rating in a report on Thursday, November 15th. Finally, UBS Group downgraded Bodycote to a “neutral” rating and reduced their target price for the stock from GBX 1,000 ($13.07) to GBX 814 ($10.64) in a report on Thursday, December 6th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of GBX 958.93 ($12.53).
BOY stock opened at GBX 788.50 ($10.30) on Thursday. Bodycote has a 1-year low of GBX 728.50 ($9.52) and a 1-year high of GBX 1,043 ($13.63).
Bodycote plc provides thermal processing services worldwide. The company operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and Hot isostatic pressing (HIP) services, including HIP product fabrication, isostatic pressing, and HIP supporting services.
Read More: Bull Market
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.